Taiwan · Delayed Price · Currency is TWD TCI GENE Statistics
Total Valuation
TCI GENE has a market cap or net worth of TWD 940.60 million. The enterprise value is 106.82 million.
| Market Cap | 940.60M |
| Enterprise Value | 106.82M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Sep 5, 2025 |
Share Statistics
TCI GENE has 26.46 million shares outstanding. The number of shares has increased by 2.67% in one year.
| Current Share Class | 26.46M |
| Shares Outstanding | 26.46M |
| Shares Change (YoY) | +2.67% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 10.93% |
| Owned by Institutions (%) | 1.51% |
| Float | 3.99M |
Valuation Ratios
The trailing PE ratio is 18.73.
| PE Ratio | 18.73 |
| Forward PE | n/a |
| PS Ratio | 3.74 |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | 8.80 |
| P/OCF Ratio | 8.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.42, with an EV/FCF ratio of 1.00.
| EV / Earnings | 2.11 |
| EV / Sales | 0.42 |
| EV / EBITDA | 3.42 |
| EV / EBIT | 5.14 |
| EV / FCF | 1.00 |
Financial Position
The company has a current ratio of 8.52, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.52 |
| Quick Ratio | 8.17 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.03 |
| Interest Coverage | 26.66 |
Financial Efficiency
Return on equity (ROE) is 5.55% and return on invested capital (ROIC) is 36.19%.
| Return on Equity (ROE) | 5.55% |
| Return on Assets (ROA) | 1.69% |
| Return on Invested Capital (ROIC) | 36.19% |
| Return on Capital Employed (ROCE) | 3.12% |
| Weighted Average Cost of Capital (WACC) | 5.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.23 |
| Inventory Turnover | 4.19 |
Taxes
| Income Tax | -52,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.35% in the last 52 weeks. The beta is 0.27, so TCI GENE's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -16.35% |
| 50-Day Moving Average | 35.70 |
| 200-Day Moving Average | 36.83 |
| Relative Strength Index (RSI) | 41.17 |
| Average Volume (20 Days) | 1,493 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TCI GENE had revenue of TWD 251.39 million and earned 50.62 million in profits. Earnings per share was 1.90.
| Revenue | 251.39M |
| Gross Profit | 144.99M |
| Operating Income | 29.22M |
| Pretax Income | 51.68M |
| Net Income | 50.62M |
| EBITDA | 33.72M |
| EBIT | 29.22M |
| Earnings Per Share (EPS) | 1.90 |
Balance Sheet
The company has 856.86 million in cash and 3.29 million in debt, with a net cash position of 853.57 million or 32.26 per share.
| Cash & Cash Equivalents | 856.86M |
| Total Debt | 3.29M |
| Net Cash | 853.57M |
| Net Cash Per Share | 32.26 |
| Equity (Book Value) | 936.80M |
| Book Value Per Share | 34.56 |
| Working Capital | 849.22M |
Cash Flow
In the last 12 months, operating cash flow was 107.16 million and capital expenditures -247,000, giving a free cash flow of 106.91 million.
| Operating Cash Flow | 107.16M |
| Capital Expenditures | -247,000 |
| Depreciation & Amortization | 4.25M |
| Net Borrowing | -10.37M |
| Free Cash Flow | 106.91M |
| FCF Per Share | 4.04 |
Margins
Gross margin is 57.67%, with operating and profit margins of 11.62% and 20.14%.
| Gross Margin | 57.67% |
| Operating Margin | 11.62% |
| Pretax Margin | 20.56% |
| Profit Margin | 20.14% |
| EBITDA Margin | 13.41% |
| EBIT Margin | 11.62% |
| FCF Margin | 42.53% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 5.88%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 5.88% |
| Dividend Growth (YoY) | -33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 104.54% |
| Buyback Yield | -2.67% |
| Shareholder Yield | 3.21% |
| Earnings Yield | 5.38% |
| FCF Yield | 11.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TCI GENE has an Altman Z-Score of 6.87 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.87 |
| Piotroski F-Score | 6 |